Health / Medical Topics

    Apomab

    A fully human monoclonal antibody directed against human death receptor 5 (DR5; TRAIL-R2; TNFRSF10B) with potential pro-apoptotic and antineoplastic activities. Mimicking the natural ligand TRAIL (tumor necrosis factor-related apoptosis inducing ligand), apomab binds to DR5, which may directly activate the extrinsic apoptosis pathway and indirectly induce the intrinsic apoptosis pathway in tumor cells. DR5 is a cell surface receptor of the TNF-receptor superfamily and is expressed in a broad range of cancers. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    A substance being studied in the treatment of hematologic (blood) cancers. Apolizumab binds to a protein called ID10, which is found on…
    The determination of the ratio of the apolipoprotein J compared to creatinine present in a sample. The measurement may be expressed as…
    The determination of the amount of apolipoprotein J present in a sample.
    The determination of the amount of apolipoprotein H present in a sample.
    The determination of the amount of apolipoprotein E4 present in a sample.
    Apolipoprotein E4 (317 aa, ~36 kDa) is encoded by the human APOE gene. This protein is involved in triglyceride metabolism.

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact